Same question here re: those 20 women.
If I remember correctly, SK and NP, during a CC last year implied they were not sure (if alive, continuing LL) and were going to research.

Submitted a related question yesterday on the CC about access to leronlimab- through right-to-try, compassionate use, whatever- for terminally ill cancer patients. It wasn't picked. (Have a dear friend that has run out of options and is finally ready to give leron a chance. Her timing stinks.)

Perhaps these two access issues are related to the FDA safety hold?

Once the FDA releases the hold- do y'all think access to leronlimab- through these processes- will be available again?